Elequin Capital »

Sarepta Therapeutics note 1.500% 11/1 shares owned by Elequin Capital

Quarter-by-quarter ownership of Sarepta Therapeutics note 1.500% 11/1 shares owned by Elequin Capital from 13F filings

Historical chart of Elequin Capital investment in Sarepta Therapeutics note 1.500% 11/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics note 1.500% 11/1 held by Elequin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics note 1.500% 11/1 by Elequin Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.9M 1.7M 1.70

More positions owned by Elequin Capital

Apple Put Option (AAPL)
Microsoft Corporation Put Option (MSFT)
NVIDIA Corporation Put Option (NVDA)
Insight Enterprises Note 0.750% 2/1 (Principal)
Microstrategy Cl A New Put Option (MSTR)
Parsons Corp Del Note 0.250% 8/1 (Principal)
Meta Platforms Cl A Put Option (META)
Broadcom Put Option (AVGO)
Grayscale Ethereum Mini Tr E Shs New
Alphabet Cap Stk Cl C Put Option (GOOG)
Bitwise Ethereum Etf SHS (ETHW)
Advanced Micro Devices Put Option (AMD)
Amazon Put Option (AMZN)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Micron Technology Put Option (MU)

View all positions for Elequin Capital

Top funds holding Sarepta Therapeutics note 1.500% 11/1

Fox Hill Wealth Management

View all funds holding Sarepta Therapeutics note 1.500% 11/1